布洛芬微粉化的研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
布洛芬是20世纪60年代开发的一种非甾体类解热镇痛消炎药,由于其难溶于水,所以存在吸收和起效慢的问题,生物利用率低,限制了它在临床上的应用。为了解决这一问题,本文将布洛芬原料药微粉化,减小布洛芬颗粒的粒径,增加其比表面积,从而提高其溶出速率及溶解度,以提高其生物利用度。
     通过对微粉化制备工艺的筛选,得到最佳制备工艺为:于250ml的锥形瓶中加入浓度为含2%的泊洛沙姆稳定剂的水溶液150ml,将其放置在0-5℃的冰水浴中,在连续式超声的条件下,以1ml/min的速度匀速滴加浓度为0.04g/ml的布洛芬乙醇溶液50ml,当溶液体系变混浊,在低温下静置6小时后,高速离心10min直至完全分离,然后将所得的固体产品再洗涤、高速离心5min,除去上清液,再将得到的产物置于50℃的真空干燥箱中干燥得到最终产品,将所得的固体产品研磨过筛,即可得到所需要的布洛芬微粉。
     通过对布洛芬原料药和微粉不同片剂体外溶出情况的考察,结果表明由布洛芬微粉制备成的普通片和缓释片在不同的溶出介质中的累积溶出率都远远大于由布洛芬原料药制备的片剂,并且由微粉制备的片剂在各种溶出介质中,在一定的时间内累计溶出率能达到或接近80%以上,溶出情况良好。对缓释片在不同溶出介质中的体外释药情况分别进了零级方式、一级方式、Higuchi方式拟合,结果表明其释药规律都符合Higuchi方程。
Ibuprofen is a kind of non-steroidal antipyretic、analgesic and anti inflammatory drugs, which was developed in 1960s.It is a kind of water-insoluble drug, as it is hard to dissolve in water, so there is the problem of low absorption、low bioavailability and low effect speed. The application in clinical medicine is limited. To solve this problem, in this research, raw ibuprofen is micronized so as to reduce particle size and increase the specify surface area, which is beneficial to enhance its dissolution and solubility, further to improve the bioavailability.
     By screening of the micronized preparation technique, the best preparation: put the 250ml conical beaker, adding 150ml poloxamer solution with 2% concentration as the stabilizer, into the ice-water bath at 0-5℃.In conditions of continuous ultrasound, dropping 50ml ibuprofen ethanol solution with 0.04g/ml concentration at 1ml/min uniform dropping rate. when the aqueous solution become turbid, standing for 6 hours at low temperature. With 10min high-speed centrifugation until solid product is completely separated from the aqueous solution, then re-washed and high-speed centrifugation 5min, remove the supernatant solution. Solid product is placed in vacuum drying oven at 50℃,then grounded and sieved by mesh.
     Through the investigation of the dissolution of different ibuprofen tablets, the results show that the accumulation dissolution rate in various dissolution media of two kinds ibuprofen micronization tablets is much larger than the ibuprofen raw material tablets. The accumulation dissolution rate of tablets that are produced with ibuprofen micronization can reach nearly 80% in a certain period of time. The research of the drug release pattern of ibuprofen micronization sustained-release tablets shows that the drug release pattern is consistent with Higuchi equation.
引文
[1]黄圣炎,非甾体解热镇痛药制剂发展现状,上海医药,2006,27(6):256-259
    [2]国家药典委员会,中华人民共和国药典2010年版二部,化学工业出版社, 2010,120
    [3]中华人民共和国药典委员会,1临床用药须知,2000年版二部:170
    [4]刘君,杜鸣.布洛芬胶囊药理毒理研究综述,黑龙江医药,2008,21(4):84-84
    [5]中国非处方药物协会,中国非处方药用药手册,北京:化学工业出版社,1999,12-15
    [6] Phleps W. Overview in clinical data of dexibuprofen.Clin Rheumatol,2001,20(Suppl I):15-21.
    [7]张娇,布洛芬的临床研究进展,中国药业,2010,5:63-64
    [8]宋舜意,冯平,布洛芬与扑热息痛临床应用观察,医药论坛杂志,2005,5(18):210-231.
    [9]侯连兵,王春霞,现代个体化药物新剂型(西药卷),北京:人民军医出版社,2009,240-243
    [10]王国联,王洁欣,反应沉淀法制备阿奇霉素药物超微粉体,过程工程学报,2007,7(4):802-806
    [11]龙涛,田熙科,杨超等,超声乳化溶剂扩散法制备阿奇霉素超细粉体,武汉大学学报,2004,50(6):665-668
    [12]李风生,姜炜,付廷明,药物粉体技术,北京:化学工业出版社,2007,159-160。
    [13]施利毅等,微乳液的结构及其在制备超细颗粒中的应用,功能材料,1998,29(2):136-139
    [14]王晓黎,蒋雪涛等,O/W型微乳对水难溶性药物增溶作用的研究,第二军医大学学报,2002,23(1):84-86
    [15]崔正刚,殷福珊,微乳化技术及应用,北京:中国轻工业出版社,1999
    [16]姚玉英,化工原理(下册),天津:天津大学出版社,2005
    [17]胡英顺,尹秋响,侯宝红等,结晶及沉淀过程中粒子聚结与团聚的研究进展,化学工业与工程,2005,25(5):371-375.
    [18] Violanto M R, Fishcher H W. Method for Making Uniformly Sized Particles from Water-insoluble Organic Compounds[P].US Pat.:4826689,1989-05-02
    [19] Chen J F, Zheng C, Chen G T. Interaction of Macro-and Micromixing on Particle Size Distribution in Reactive Precipitation. Chem. Eng. Sci., 1996, 51(10): 1957-1966.
    [20] Mishima K, Matsuyama K, Uchiyama H, Microcoating of flavones and 3-hydroxyflavone with polymer using supercritical carbon dioxide.4th ed.Internation Symposium on Supercritical Fluids.Japan:sendai,1997,267-273
    [21] Tsutsumi A, Nakamoto S, Mineo T, et al. A novel fluidized-bed coating of fine particles by rapid expansion of supercritical fluid solutions.Powder Technol,1995,85(3):275-278
    [22] Yeo S D,Lim G B, Debenedetti P G.Formation of microparticulate protein powers using a supercritical fluid antisolvent. Biotech bioeng,1993,41(30):341-346
    [23] Randolph T W, Randolpa A D, Mebes M. Submicrometer-sized biodegradable particles of poly(Llactic acid) via the gas antisolvent spray precipitationprocessi. Biotechnol Prog,1993,9(4):429-435
    [24]高尧来等,超临界流体制备超微粉体的研究进展,化学工业与工程,2002,19(6):466-470
    [25] Adschiri T,Kanazawa K, Arai K.Rapid and continuous-hydrothermal crystallization of metal oxide particles in supercritical water. J Am Ceram Soc,1992,75(8):1019-1022
    [26]李志义等,超临界流体过程,与药物超细化,中国新药杂志,2004,13(3):238-242
    [27]贺文智等,超临界流体沉淀技术制备超细粒子研究,化工进展,2003,15(5):362-366
    [28] Iwai Y,Koga Y,Maruyama H.Solubilities of stearic acid,stearyl alcohol and arachidyl alcohol in supercritical carbon dioxide at 35℃.J Chem Eng Data,1993,38(4):506-508
    [29]胡国勤等,超临界流体制备超细微粒技术及其在药物制剂方面的应用,中国医药工业杂志,2003,34(1):44
    [30]刘永霞,于才渊,微胶囊技术的应用及其发展,中国粉体技术,2003,9(3):36-40
    [31]王显伦,锐孔法制备微胶囊技术研究,郑州粮食学院学报,1995,16(4):21-26
    [32]盖国胜,超微粉体技术,北京:化学工业出版社,2004
    [33]卢寿慈,粉体技术手册,北京:化学工业出版社,2004
    [34]王乃宁,颗粒粒径的光学测量技术及应用,北京:原子能出版社,1999,38-45
    [35]邓勃,王庚辰,汪政范,分析仪器与仪器分析概论,北京:化学工业出版社,2005
    [36]李津明,现代制药技术,北京:中国医药科技出版社,2005,10-11
    [37] Koichi ITOH, Adchara PONGPEERAPAT, Yuichi TOZUKA, et al, Nanoparticle Formation of poorly Water-Soluble Drugs from Ternary Ground Mixture with PVP and SDS. Chem Pharm Bull,2003,51(20):171-174
    [38]徐铮奎,微粉药物制剂开发研究新进展,中国制药信息,2003,l9( 6):12-13
    [39]陈兴权,于慧杰,郁威,超临界流体快速膨胀法制备物质微粉:Ⅰ,布洛芬微粉的制备,中国医药工业杂志,2002,33:227-228,260
    [40] Foster N R, Dehghani F, Charoenchaitrakool M, et al. Application of dense gas techniques for the production of fine particles. AAPS Pharm Sci,2003,5:105-111
    [41]周敏毅,陈建峰,刘晓林,重结晶微粉化提高布洛芬溶出度,北京化工大学学报, 2003, 30(4): 6-8
    [42] Yong C S ,Yang C H,Rhee J D,et a1.Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 1 88 and mentho1.Int J Pharm,2004 ,269:169
    [43]龙晓英,杨帆,陈立豪等,布洛芬口腔崩解片的制备及质量检查,中国医药工业杂志, 2004, 35(7): 407-409
    [44]孔敬田,布洛芬口腔崩解片的研制,齐鲁药事, 2005, 24(10):620-622
    [45]张淑芸,难溶性药物布洛芬的药剂学研究进展,海峡药学,2007,12(19):10-12
    [46]刘锋,唐星,张华丽等,重结晶法增加布洛芬生物利用度,中国医院药学杂志, 1992, 12(12):553-554
    [47]赵焰,孙延清,布洛芬分散片的研制,山东大学学报(医学版),2002,40(2):131-132
    [48]洪怡,肖学成,薛大全,右旋布洛芬缓释片的制备及其释放度测定,中国药师,2006,9(9):861-862
    [49]彭永富,董慧,药物溶出度Weibull分布的计算机求解,中国药学杂志,1996,31(10):607
    [50]杨友春,微型计算机在临床药理中的应用,南京:江苏科学技术出版社, 1989:223